Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

3.550 +0.120 (+3.50%)

Streaming Delayed Price Updated: 3:59 PM EDT, Mar 9, 2026 Add to My Watchlist

Price and Volume

Volume	6,039
Open	3.350
Bid (Size)	3.400 (100)
Ask (Size)	3.600 (100)
Prev. Close	3.430
Today's Range	3.350 - 3.600
52wk Range	2.521 - 7.000
Shares Outstanding	2,084,016,678
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit

Today 7:25 EDT

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

March 04, 2026

– Neurology and Movement Disorder Specialist Adds Deep Clinical and Development Expertise –

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Performance

YTD	+12.3%	+12.3%
1 Month	+0.6%	+0.6%
3 Month	+7.9%	+7.9%
6 Month	-31.3%	-31.3%
1 Year	-2.3%	-2.3%

More News

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments

March 02, 2026

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

January 30, 2026

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

January 21, 2026

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

November 12, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System

November 10, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

October 31, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 09, 2025

Via Benzinga

Thursday's after hours session: top gainers and losers ↗

October 09, 2025

Via Chartmill

Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

October 09, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

October 02, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting

September 15, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Raises A$20.0 million in Strategic Placement

September 08, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics to Present at the Biotech Showcase

September 02, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

July 30, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

July 28, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

July 24, 2025

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 11, 2025

Via Benzinga

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗

July 11, 2025

Via Benzinga

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?

Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.

What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?

Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?

The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market

What is the current price of Alterity Therapeutics Limited - American Depositary Shares?

The current price of Alterity Therapeutics Limited - American Depositary Shares is 3.550

When was Alterity Therapeutics Limited - American Depositary Shares last traded?

The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 03/09/26 03:59 PM ET

What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?

The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 7.40B

How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?

Alterity Therapeutics Limited - American Depositary Shares has 7B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.